World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 19 February 2015
Main ID:  NCT00377910
Date of registration: 18/09/2006
Prospective Registration: Yes
Primary sponsor: Northern Orthopaedic Division, Denmark
Public title: The Efficacy of Polidocanol Injections as a Treatment of Chronic Achilles. Tendinopathy
Scientific title: Placebo Controlled Trial, Testing the Efficacy of Polidocanol Injections as a Treatment of Chronic Achilles Tendinopathy.
Date of first enrolment: March 2008
Target sample size: 48
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT00377910
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Factorial Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment  
Phase:  Phase 4
Countries of recruitment
Denmark
Contacts
Name:     Ole Simonsen, MD, DMSci
Address: 
Telephone:
Email:
Affiliation:  Northern Orthopaedic Division, Denmark
Key inclusion & exclusion criteria

Inclusion Criteria:

- 18 year old, Ultrasound verified Achilles tendinopathy with neo-vascularisation, pain
duration more than three months, excentric exercises for at least three months,
women: negative pregnancy test, safe anticonceptive

Exclusion Criteria:

- Dementia, mental disease or other illness incompatible with participation, no
ultrasound verified neo-vascularisation, any illness which contraindicate the use of
Polidocanol or Lidocaine, granulation tissue of more than 50 % of the Achilles
tendon, ability of lying in prone position, women: pregnancy or breastfeeding,



Age minimum: 18 Years
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
Chronic Achilles Tendinopathy
Intervention(s)
Drug: Aethoxysclerol
Primary Outcome(s)
Pain during physical activity which usually causes pain [Time Frame: 3 and 6 months]
Secondary Outcome(s)
Patient evaluation of treatment efficacy [Time Frame: 3 and 6 months]
Number of neo-vascularisation. [Time Frame: day 0, 1 and 3 months]
AOFAS [Time Frame: 3 and 6 months]
Achilles tendon pressure measuring until pain release. [Time Frame: 3 and 6 months]
FAOS [Time Frame: 3 and 6 months]
Localisation of the neo-vascularisation [Time Frame: day 0, 1 and 3 months]
Pain while resting. [Time Frame: 3 and 6 months]
Secondary ID(s)
ON-02-012-OSi
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Aarhus University Hospital
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history